162 related articles for article (PubMed ID: 20956959)
61. Plasma levels of IL-7 and IL-15 after reduced intensity conditioned allo-SCT and relationship to acute GVHD.
Thiant S; Labalette M; Trauet J; Coiteux V; de Berranger E; Dessaint JP; Yakoub-Agha I
Bone Marrow Transplant; 2011 Oct; 46(10):1374-81. PubMed ID: 21132028
[TBL] [Abstract][Full Text] [Related]
62. Bendamustine combined with donor lymphocytes infusion in Hodgkin's lymphoma relapsing after allogeneic hematopoietic stem cell transplantation.
Sala E; Crocchiolo R; Gandolfi S; Bruno-Ventre M; Bramanti S; Peccatori J; Sarina B; Corti C; Ciceri F; Santoro A; Marktel S; Castagna L
Biol Blood Marrow Transplant; 2014 Sep; 20(9):1444-7. PubMed ID: 24907625
[TBL] [Abstract][Full Text] [Related]
63. Comparative analysis of post-transplant lymphoproliferative disorder after kidney transplantation versus hematopoietic stem cell transplantation.
Yoon JH; Lee S; Kim HJ; Lee JW; Min WS; Chung BH; Yang CW; Kim YS; Kim JI; Moon IS; Oh EJ; Park GS; Cho SG
Transpl Int; 2014 Jul; 27(7):721-32. PubMed ID: 24684689
[TBL] [Abstract][Full Text] [Related]
64. Effect of Irradiation on Incidence of Post-Transplant Lymphoproliferative Disorder after Hematopoietic Cell Transplantation in Miniature Swine.
Matar AJ; Patil AR; Al-Musa A; Hanekamp I; Sachs DH; Huang CA; Duran-Struuck R
Biol Blood Marrow Transplant; 2015 Oct; 21(10):1732-8. PubMed ID: 26210443
[TBL] [Abstract][Full Text] [Related]
65. The role of allogeneic stem-cell transplantation in Hodgkin's disease.
Schmitz N; Sureda A
Eur J Haematol Suppl; 2005 Jul; (66):146-9. PubMed ID: 16007884
[TBL] [Abstract][Full Text] [Related]
66. Late Complications and Quality of Life after Reduced-Intensity Conditioning Allogeneic Stem Cell Transplantation.
Clavert A; Peric Z; Brissot E; Malard F; Guillaume T; Delaunay J; Dubruille V; Le Gouill S; Mahe B; Gastinne T; Blin N; Harousseau JL; Moreau P; Milpied N; Mohty M; Chevallier P
Biol Blood Marrow Transplant; 2017 Jan; 23(1):140-146. PubMed ID: 27751934
[TBL] [Abstract][Full Text] [Related]
67. Incidence and management of hepatic venoocclusive disease in 237 patients undergoing reduced-intensity conditioning (RIC) haematopoietic stem cell transplantation (HSCT).
Ramasamy K; Lim ZY; Pagliuca A; Grundy R; Devereux S; Ho AY; Mufti GJ
Bone Marrow Transplant; 2006 Dec; 38(12):823-4. PubMed ID: 17057726
[No Abstract] [Full Text] [Related]
68. Impact of reduced-intensity conditioning allogeneic stem cell transplantation on women's fertility.
Assouline E; Crocchiolo R; Prebet T; Broussais F; Coso D; Gamerre M; Vey N; Blaise D; Courbiere B
Clin Lymphoma Myeloma Leuk; 2013 Dec; 13(6):704-10. PubMed ID: 24070823
[TBL] [Abstract][Full Text] [Related]
69. Reduced-intensity conditioning (RIC) and allogeneic stem cell transplantation (allo-SCT) for relapsed/refractory Hodgkin lymphoma (HL) in the brentuximab vedotin era: favorable overall and progression-free survival (OS/PFS) with low transplant-related mortality (TRM).
Clin Adv Hematol Oncol; 2014 Feb; 12(2 Suppl 6):15-7. PubMed ID: 24870877
[No Abstract] [Full Text] [Related]
70. Incidence and risk factors for hypogammaglobulinemia in pediatric patients following allo-SCT.
Frangoul H; Min E; Wang W; Chandrasekhar R; Calder C; Evans M; Manes B; Bruce K; Brown V; Ho R; Domm J
Bone Marrow Transplant; 2013 Nov; 48(11):1456-9. PubMed ID: 23708706
[TBL] [Abstract][Full Text] [Related]
71. [The risk factors of post-transplant lymphoproliferative disorders following haploidentical hematopoietic stem cell transplantation].
Zhang C; Huang X; Liu D; Mo X; Zhang X; Chen H; Han W; Chen Y; Wang Y; Wang J; Wang F; Zhao T; Liu Y; Liu K; Xu L
Zhonghua Nei Ke Za Zhi; 2014 Jul; 53(7):527-31. PubMed ID: 25264006
[TBL] [Abstract][Full Text] [Related]
72. [Reduced intensity allogenic hematopoietic stem cell transplantation in children].
Paillard C; Lutz P; Michel G; Leverger G; Dalle JH; Demeocq F; Kanold J
Bull Cancer; 2011 May; 98(5):541-8. PubMed ID: 21576045
[TBL] [Abstract][Full Text] [Related]
73. Brentuximab vedotin in combination with or without donor lymphocyte infusion for patients with Hodgkin lymphoma after allogeneic stem cell transplantation.
Tsirigotis P; Danylesko I; Gkirkas K; Shem-Tov N; Yerushalmi R; Stamouli M; Avigdor A; Spyridonidis A; Gauthier J; Goldstein G; Apostolidis J; Mohty M; Shimoni A; Nagler A
Bone Marrow Transplant; 2016 Oct; 51(10):1313-1317. PubMed ID: 27183095
[TBL] [Abstract][Full Text] [Related]
74. EBV-related disease following haematopoietic stem cell transplantation with reduced intensity conditioning.
Cohen JM; Cooper N; Chakrabarti S; Thomson K; Samarasinghe S; Cubitt D; Lloyd C; Woolfrey A; Veys P; Amrolia PJ
Leuk Lymphoma; 2007 Feb; 48(2):256-69. PubMed ID: 17325885
[TBL] [Abstract][Full Text] [Related]
75. Hematopoietic progenitor cells transplantation for recurrent or refractory Hodgkin's lymphoma.
Moscato T; Fedele R; Messina G; Irrera G; Console G; Martino M
Expert Opin Biol Ther; 2013 Jul; 13(7):1013-27. PubMed ID: 23586758
[TBL] [Abstract][Full Text] [Related]
76. Reduced-intensity conditioning allogeneic stem cell transplantation in pediatric patients and subsequent supportive care.
Barrell C; Dietzen D; Jin Z; Pinchefsky S; Petrillo K; Satwani P
Oncol Nurs Forum; 2012 Nov; 39(6):E451-8. PubMed ID: 23107858
[TBL] [Abstract][Full Text] [Related]
77. Allogeneic transplantation of hematopoietic stem cells after nonmyeloablative conditioning for Hodgkin's disease: indications and results.
Schmitz N; Sureda A; Robinson S
Semin Oncol; 2004 Feb; 31(1):27-32. PubMed ID: 14970934
[TBL] [Abstract][Full Text] [Related]
78. Allogeneic stem cell transplantation for mantle cell lymphoma--does it deserve a better look?
Rifkind J; Mollee P; Messner HA; Lipton JH
Leuk Lymphoma; 2005 Feb; 46(2):217-23. PubMed ID: 15621804
[TBL] [Abstract][Full Text] [Related]
79. Lower respiratory tract respiratory virus infections increase the risk of invasive aspergillosis after a reduced-intensity allogeneic hematopoietic SCT.
Martino R; Piñana JL; Parody R; Valcarcel D; Sureda A; Brunet S; Briones J; Delgado J; Sánchez F; Rabella N; Sierra J
Bone Marrow Transplant; 2009 Dec; 44(11):749-56. PubMed ID: 19398963
[TBL] [Abstract][Full Text] [Related]
80. High-dose Chemotherapy with Stem Cell Rescue Provided Durable Remission for Classical Hodgkin Lymphoma-type Post-transplant Lymphoproliferative Disorder after Unrelated Cord Blood Transplantation: A Case Report and Review of the Literature.
Itonaga H; Kato T; Fujioka M; Taguchi M; Taniguchi H; Imaizumi Y; Yoshida S; Miyoshi H; Moriuchi Y; Ohshima K; Miyazaki Y
Intern Med; 2017; 56(14):1873-1877. PubMed ID: 28717085
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
